On 15 June 2026, Belgium kindly hosted representatives of the Beneluxa Initiative at RIZIV-INAMI in Brussels for the biannual Steering Committee Meeting. The meeting provided an opportunity for member states to take stock of current work, exchange national updates, and set...
The Beneluxa Initiative aims to ensure sustainable access
to innovative medicine at affordable cost for our patients.
Steering Committee Meeting of the Beneluxa Initiative in Brussels, Belgium
Statement of the Beneluxa Initiative on a more unified European approach to access to and affordability of pharmaceutical products
The Beneluxa Initiative believes the current developments in the pharmaceutical system require coordination - to safeguard long-term affordable pharmaceutical care for European patients, while providing a strong and targeted approach to innovation in Europe. We call for: Deeper...
The Beneluxa Initiative identified impactful medicines suitable for joint HTA submission
Products on this list have been selected as they are of interest for a joint HTA only or combined with a joint negotiation to three or more countries within Beneluxa. The list draws from the work under IHSI high impact reports and ongoing products under the scope of the EU HTA...